FDG uptake in inferior vena cava tumor thrombus from renal cell carcinoma on positron emission tomography

Clinical Nuclear Medicine

Volumn 32, Issue 4, 2007, Pages 309-311

  Sizemore, Alecia W ^a   Jacobs, Martin P ^a   Mantil, Joseph C ^a   Hahm, Geoffrey K ^a  

^a KETTERING MEDICAL CENTER   (United States)

Author keywords

F 18 fluorodeoxyglucose; Inferior vena cava; Positron emission tomography; Renal cell carcinoma; Tumor thrombus

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DIAPHRAGM; DRUG ACCUMULATION; FEMALE; HISTOLOGY; HUMAN; INFERIOR CAVA VEIN; KIDNEY CARCINOMA; KIDNEY VEIN; NEPHRECTOMY; POSITRON EMISSION TOMOGRAPHY; TUMOR LOCALIZATION; TUMOR THROMBUS; VEIN DISEASE;

AGED; CARCINOMA, RENAL CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEPATIC VEIN THROMBOSIS; HUMANS; KIDNEY NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; VENA CAVA, INFERIOR;

EID: 34147107048     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000257277.80226.aa     Document Type: Article

References (14)

1. US Cancer Statistics Working Group. United States Cancer Statistics: 2002 Incidence and Mortality. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2005.
2. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med. 1996;335:865-875.
3. Lawrentschuk N, Davis ID, Bolton DM, et al. Positron emission tomography (PET), immuno-PET and radioimmunotherapy in renal cell carcinoma: a developing diagnostic and therapeutic relationship. BJU Int. 2006;97:916-922.
4. Schöder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med. 2004;34:274 -292.
5. Kang DE, White RLJ, Zuger JH, et al. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol. 2004;171:1806-1809.
6. Sydow BD, Srinivas SM, Newberg A, et al. Deep venous thrombosis on F-18 FDG PET/CT imaging. Clin Nucl Med. 2006;31:403-404.
7. Nguyen BD. Pancreatic neuroendocrine tumor with portal vein tumor thrombus: PET demonstration. Clin Nucl Med. 2005;30:628-629.
8. Gupta P, Kramer EL, Ponzo F. FDG uptake in tumor thrombus in inferior vena cava from rectal cancer on positron emission tomography. Clin Nucl Med. 2005;30:342-343.
9. Defawe OD, Hustinx R, Defraigne JO, et al. Distribution of F-18 fluorodeoxyglucose (F-18 FDG) in abdominal aortic aneurysm: high accumulation in macrophages seen on PET imaging and immunohistology. Clin Nucl Med. 2005;30:340-341.
10. Siosteen AK, Celsing F, Jacobsson H. FDG uptake in a catheter-related thrombus simulating relapse of lymphoma. Clin Nucl Med. 2005;30:338-339.
11. Chang KJ, Zhuang H, Alavi A. Detection of chronic recurrent lower extremity deep venous thrombosis on fluorine-18 fluorodeoxyglucose positron emission tomography. Clin Nucl Med. 2000;25:838-839.
12. Lin EC, Quaife RA. FDG uptake in chronic superior vena cava thrombus on positron emission tomographic imaging. Clin Nucl Med. 2001;26:241-242.
13. Miceli M, Atoui R, Walker R, et al. Diagnosis of deep septic thrombophlebitis in cancer patients by fluorine-18 fluorodeoxyglucose positron emission tomography scanning: a preliminary report. J Clin Oncol. 2004;22:1949-1956.
14. Cotran RS, Kumar V, Collins T. Robbins Pathologic Basis of Disease: Tumors of the Kidney. Philadelphia, PA: WB Saunders; 1999:990-994.